Kn. Ting et al., STUDIES ON THE VASOCONSTRICTOR ACTION OF MELATONIN AND PUTATIVE MELATONIN RECEPTOR LIGANDS IN THE TAIL ARTERY OF JUVENILE WISTAR RATS, British Journal of Pharmacology, 122(7), 1997, pp. 1299-1306
1 In this study we compared the vasoconstrictor activity of melatonin
in rat isolated tail artery using two different recording systems, the
Halpern pressure myograph and the Halpern-Mulvany wire myograph, with
the view to determining a reliable method for obtaining pharmacologic
al data on vascular melatonin receptors. In addition, we characterized
the melatonin receptor in this preparation, using analogues of melato
nin, and examined the activity of various naphthalenic derivatives wit
h biological activity in non-vascular models of melatonin receptors. 2
Using the Halpern pressure myograph, cumulative addition of melatonin
(0.1 nM to 1 mu M) produced direct vasoconstriction (19.3+/-6.4% redu
ction in lumen diameter, n=5) in five of 11 pressurized segments, with
pEC(50) of 9.14+/-0.17. Similarly, non-cumulative application of mela
tonin caused vasoconstriction (19.7+/-4.6% reduction in lumen diameter
, n=7) in seven of 20 preparations examined with pEC(50) of 8.74+/-0.2
6. The selective alpha(2)-adrenoceptor agonist, UK-14304 (5-bromo-6-[2
-imidazolin-2-ylamino]-quinoxaline bitartrate), produced vasoconstrict
ion in all 'melatonin-insensitive' preparations. 3 Melatonin (0.1 nM t
o 1 mu M) failed to elicit isometric contractions of tail artery segme
nts in the Halpern wire myograph, but produced concentration-dependent
potentiation of electrically-evoked, isometric contractions (maximum
effect of 150-200% enhancement) when applied either noncumulatively (s
even of seven preparations) or cumulatively (four of seven preparation
s). The pEC(50) value of melatonin (non-cumulative) was 8.50+/-0.10 (n
=7) which was not different from that obtained in the pressure myograp
h. All further experiments were conducted using a non-cumulative proto
col against electrically-evoked, isometric contractions. 4 Based on th
e pEC(50) values for the melatonin analogues examined, the pharmacolog
ical profile for the enhancement of electrically-evoked contractions w
as 2-iodomelatonin > 6-chloromelatonin greater than or equal to (-)-AM
MTC greater than or equal to S21634 greater than or equal to melatonin
greater than or equal to S20098 > S20242 greater than or equal to S20
304 > 6-hydroxymelatonin > S20932 > (+)-AMMTC > N-acetyl-5-HT. Our dat
a suggests the vascular receptor belongs to the MELi-like subtype. All
the indole-based analogues of melatonin, 2-iodomelatonin, (-)-AMMTC,
(+)-AMMTC, S20932, 6-chloromelatonin, 6-hydroxymelatonin and N-acetyl-
5-HT, behaved as full agonists. All the naphthalenic derivatives exami
ned, S21634, S20098, S20242 and S20304 behaved as partial agonists rel
ative to melatonin. 5 The naphthalenic-based antagonists, S20928 and S
20929, did not modify electrically-evoked, isometric contractions of t
he tail artery, but produced a parallel, rightward displacement of the
melatonin concentration-response curve. Based upon the effect of 1 mu
M S20928 and S20929, the estimated pK(B) values for these antagonists
were 7.18+/-0.25 (n=4) and 7.17+/-0.25 (n=5), respectively.6 We demon
strated that enhancement of electrically-evoked, isometric contraction
s of the rat isolated tail artery (using the Halpern-Mulvany wire myog
raph) is a simple and reproducible model for assessing the activity of
putative agonists, partial agonists and antagonists at vascular melat
onin receptors. Pharmacological characterization of the receptor sugge
sts the presence of a MEL1-like subtype.